News that there may be a link between implanted RFID chips and cancer in mice and rats sent VeriChip shares plunging by as much as 14 percent on Tuesday. The company’s troubles began over the weekend when results of three studies in the United States and Europe detailing the increased risk — which was found to range between 1 percent and 10 percent in rodents that received implanted chips — emerged in press reports. VeriChip disputes the findings, noting that the VeriMed Patient Identification System, has been cleared by the Food and Drug Administration.
Loading ...
Possible RFID-Cancer Link Rattles Market
Posted by: Erika Morphy September 11, 2007 03:37 PMNews that there may be a link between implanted RFID chips and cancer in mice and rats sent VeriChip shares plunging by as much as 14 percent on Tuesday. The company’s troubles began over the weekend when results of three studies in the United States and Europe detailing the increased risk — which was found to range between 1 percent and 10 percent in rodents that received implanted chips — emerged in press reports. VeriChip disputes the findings, noting that the VeriMed Patient Identification System, has been cleared by the Food and Drug Administration.